25エピソード

Join FDA leaders as they provide their insight into issues facing the agency – including the COVID-19 pandemic and other emerging topics. The program will be on hiatus starting Jan. 20, 2021.

FDA Insight U.S. Food and Drug Administration

    • 行政

Join FDA leaders as they provide their insight into issues facing the agency – including the COVID-19 pandemic and other emerging topics. The program will be on hiatus starting Jan. 20, 2021.

    Pandemic Recovery and Preparedness Plan (PREPP)

    Pandemic Recovery and Preparedness Plan (PREPP)

    Join FDA Commissioner Stephen M. Hahn, M.D. and Deputy Commissioner for Medical and Scientific Affairs Anand Shah, M.D. for their final episode of FDA Insight as they discuss FDA’s Pandemic Recovery and Preparedness Plan, or PREPP. After this episode, the program is scheduled to go on hiatus.

    • 11分
    New Era of Smarter Food Safety

    New Era of Smarter Food Safety

    Frank Yiannas, FDA’s Deputy Commissioner for Food Policy and Response, joins Dr. Shah for a discussion on the New Era of Smarter Food Safety and how its blueprint impacts FDA’s COVID-19 response.

    • 19分
    Compounded Drugs

    Compounded Drugs

    Gail Bormel from the Office of Compliance in FDA’s Center for Drug Evaluation and Research joins Dr. Shah for a discussion on drug compounding and its contribution to fighting COVID-19.

    • 10分
    Advanced Manufacturing

    Advanced Manufacturing

    Dr. Jeffrey C. Baker, Deputy Director of the FDA’s Office of Biotechnology Products in the Center for Drug Evaluation and Research, joins Dr. Shah for a discussion on how FDA’s efforts help innovation and implementation of Advanced Manufacturing technologies regarding food and drug safety.

    • 11分
    Minority Health and Health Equity

    Minority Health and Health Equity

    Dr. Anand Shah and Rear Adm. Richardae Araojo, Associate Commissioner of Minority Health, discuss the FDA’s efforts to address minority health disparities among diverse racial and ethnic populations.

    • 13分
    Rare Diseases and Orphan Products

    Rare Diseases and Orphan Products

    Dr. Shah welcomes Dr. Janet Maynard, director of FDA’s Office of Orphan Products Development, for a discussion on the agency’s work advancing evaluation and development of products that demonstrate promise for the diagnosis and treatment of rare diseases.

    • 15分

行政のトップPodcast

他のリスナーはこちらのサブスクリプションにも登録しています